| ID Source | ID |
|---|---|
| PubMed CID | 18065 |
| SCHEMBL ID | 259964 |
| MeSH ID | M0179725 |
| Synonym |
|---|
| phosphorodithioic acid, o,o,s-trimethyl ester |
| o,o,s-trimethyl dithiophosphate |
| o,o,s-trimethylphosphorodithionate |
| o,o,s-trimethylphosphorodithioate |
| brn 1702943 |
| ai3-27482 |
| AKOS006277646 |
| 2953-29-9 |
| 8ow97x1u88 , |
| unii-8ow97x1u88 |
| o,o,s- trimethyl dithiophosphate |
| 4-01-00-01286 (beilstein handbook reference) |
| SCHEMBL259964 |
| ILDHFYGNYDICFB-UHFFFAOYSA-N |
| o,o,s-trimethyl phosphorodithioate |
| methyl phosphorodithioate ((meo)2(mes)ps) |
| trimethyl phosphorodithiate, o,o,s- |
| DTXSID2042226 |
| o,o,s-trimethyldithiophosphate |
| dimethoxy-methylsulfanyl-sulfanylidene-lambda5-phosphane |
| dithiophosphoric acid o,o',s-trimethyl ester |
| EN300-108463 |
| Q27270828 |
| o,o-dimethyl (methylsulfanyl)phosphonothioate |
| CAA95329 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " Pretreatment with Aroclor 1254 or beta-naphthoflavone (beta-NF) did not alter the LD50 of 1-NN." | ( 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity. Carthew, P; Dinsdale, D; Verschoyle, RD; Wolf, CR, 1993) | 0.29 |
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to test the hypothesis that the reduction in cytochrome P450 (CYP) 2B1 content and activity of rat lung microsomes, following dosing with pneumotoxic trimethylphosphorothioates, results from damage to specific cell types." | ( Cell-specific loss of cytochrome P450 2B1 in rat lung following treatment with pneumotoxic and non-pneumotoxic trialkylphosphorothioates. Dinsdale, D; Verschoyle, RD, 2001) | 0.31 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.31) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||